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Abstract
The active vitamin D metabolite, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), has been shown to be an important regulator of
innate and adaptive immune function. In addition, synthesis of 1,25(OH)2D3 from 25-hydroxyvitamin D3 (25(OH)D3) by the
enzyme 1a-hydroxylase in monocytes upon activation by TLR signaling has been found to regulate innate immune
responses of monocytes in an intracrine fashion. In this study we wanted to determine what cells expressed 1a-hydroxylase
in stimulated peripheral blood mononuclear cell (PBMC) cultures and if conversion of 25(OH)D3 to 1,25(OH)2D3 in PBMC
cultures regulated antigen-specific immune responses. Initially, we found that stimulation of PBMCs from animals
vaccinated with Mycobacterium bovis (M. bovis) BCG with purified protein derivative of M. bovis (M. bovis PPD) induced 1a-
hydroxylase gene expression and that treatment with a physiological concentration of 25(OH)D3 down-regulated IFN-c and
IL-17F gene expression. Next, we stimulated PBMCs from M. bovis BCG-vaccinated and non-vaccinated cattle with M. bovis
PPD and sorted them by FACS according to surface markers for monocytes/macrophages (CD14), B cells (IgM), and T cells
(CD3). Sorting the PBMCs revealed that 1a-hydroxylase expression was induced in the monocytes and B cells, but not in the
T cells. Furthermore, treatment of stimulated PBMCs with 25(OH)D3 down-regulated antigen-specific IFN-c and IL-17F
responses in the T cells, even though 1a-hydroxylase expression was not induced in the T cells. Based on evidence of no T
cell 1a-hydroxylase we hypothesize that activated monocytes and B cells synthesize 1,25(OH)2D3 and that 1,25(OH)2D3
down-regulates antigen-specific expression of IFN-c and IL-17F in T cells in a paracrine fashion.
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Introduction
Substantial evidence supports the notion that vitamin D
insufficiency (serum 25(OH)D3 concentrations ,32 ng/mL or
80 nM) results in inadequate immune function and thus increased
risk for infectious and autoimmune diseases [1]. For instance, an
inverse correlation exists between serum 25(OH)D3 and the risk
for upper respiratory tract infections [2], tuberculosis [3,4], and
multiple sclerosis [5,6]. Vitamin D supplementation also decreases
the risk influenza A infection [7], decreases the relapse rate in
multiple sclerosis patients [8], and enhances ex vivo immunity to
Mycobacteria tuberculosis [9]. The actions of 1,25-dihydroxyvitamin
D3 (1,25(OH)2D3; the active hormone) on innate and adaptive
immunity and the ability of immune cells to synthesize
1,25(OH)2D3 [10] provides further evidence for a link between
vitamin D status and immune function. Understanding the
mechanisms of vitamin D signaling in the immune system,
consequently, provides critical insight for the vitamin D require-
ments of the immune system.
The vitamin D hormone has been known for some time to
regulate key responses of innate and adaptive immunity. The
actions of 1,25(OH)2D3 on the immune system occur through the
vitamin D receptor (VDR). The VDR is present in most
populations of immune cells [11,12,13] and controls the
expression of genes that have promoters with accessible vitamin
D response elements [14,15]. In human monocytes and macro-
phages, 1,25(OH)2D3 induces cathelicidin, CD14, defensin beta 4,
and NOD2 gene expression [16,17,18,19]. In contrast to human
monocytes, 1,25(OH)2D3 enhances inducible nitric oxide synthase
(iNOS) and RANTES/CCL5 gene expression in bovine mono-
cytes [20]. In regards to adaptive immunity, 1,25(OH)2D3 is a
potent suppressor of lymphocyte proliferation and this has been
observed for humans, cattle, and mice [21,22,23,24]. In addition,
1,25(OH)2D3 suppresses IFN-c responses of T cells from humans,
cattle and mice in vitro [25,26,27,28,29]. Recently, 1,25(OH)2D3
also was found to suppress IL-17A responses of human and mouse
T cells [25,30,31]. In mouse models of autoimmune disease,
1,25(OH)2D3 suppresses Th1 and Th17-mediated inflammation
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1,25(OH)2D3-mediated inhibition of experimental autoimmune
encephalomyelitis (EAE) [35]. Altogether, in vitro and in vivo
evidence show that 1,25(OH)2D3 acts on immune cells to regulate
both innate and adaptive immunity, and that the actions of
1,25(OH)2D3 on adaptive immunity are similar among humans,
cattle and mice.
The metabolism of 1,25(OH)2D3 is critical for immune function
because of the potent effects of 1,25(OH)2D3 on innate and
adaptive immunity. The enzyme that synthesizes 1,25(OH)2D3
from 25-hydroxyvitamin D3 (25(OH)D3)i s1 a-hydroxylase (1a-
OHase) [36]. In the vitamin D endocrine system, 1a-OHase is
expressed in the kidney and is tightly regulated in response to
calcium homeostasis via the parathyroid hormone in order to
control the circulating concentration of 1,25(OH)2D3 [37].
However, the circulating concentration of 1,25(OH)2D3 does not
affect vitamin D-mediated immune responses [38,39] and
circulating 1,25(OH)2D3 does not increase when the immune
system is activated [40]. Rather, monocytes and macrophages
express 1a-OHase in response to toll-like receptor (TLR) signaling,
and this has been shown for humans, cattle, and mice [20,41,42].
In addition, dendritic cells, B cells and T cells also have been
found to express 1a-OHase to some degree upon activation
[43,44]. However, 1a-OHase is predominantly upregulated in the
CD14
+ cells (monocytes/macrophages) from the inflamed mam-
mary gland during mastitis in cattle [45]. Consequently, induction
of 1a-OHase in immune cells enables regulation of 1,25(OH)2D3
concentration at sites of inflammation and this localized regulation
is evident from animal models of inflammation. In cattle, the gene
for 24-hydroxylase, the vitamin D catabolic enzyme that is highly
upregulated by 1,25(OH)2D3, is expressed much higher in
inflamed mammary tissue than in healthy tissue or circulating
immune cells during mastitis [45]. Also in cattle, 1,25(OH)2D3
accumulated in granulomas during tuberculosis [46]. Finally, the
concentration of 1,25(OH)2D3 increased in the spinal cords of
mice during EAE, but did not change in serum [47]. Therefore,
the immune system has a mechanism to control 1,25(OH)2D3
concentration locally independent of the endocrine system.
Subsequently, local control of 1,25(OH)2D3 metabolism by the
immune system has been shown to have a significant impact on
innate immunity [48]. For example, synthesis of 1,25(OH)2D3 by
1a-OHase in human monocytes induces their expression of
cathelicidin [41]. Similarly, synthesis of 1,25(OH)2D3 by 1a-
OHase in bovine monocytes enhances their expression of iNOS
and RANTES [20]. So, 1,25(OH)2D3 produced in monocytes acts
in an intracrine fashion to regulate vitamin-responsive genes.
As for adaptive immunity, monocyte production of
1,25(OH)2D3 has been suggested to also regulate T cell responses
in a paracrine fashion [48]. However, lymphocytes also may be a
source of 1,25(OH)2D3 and regulation of antigen-specific immune
responses of T cells by conversion of 25(OH)D3 to 1,25(OH)2D3 in
either monocytes or lymphocytes has yet to be shown. Therefore,
the objectives of this study were to evaluate 1a-OHase gene
expression in PBMC cultures in response to antigen stimulation
and determine the effects of 25(OH)D3 on innate and adaptive
immune responses in PBMC cultures.
To accomplish the objectives of this study we use PBMCs from
calves vaccinated with Mycobacterium bovis bacilli Calmette-Guerin
(M. bovis BCG), which elicits strong IFN-c and IL-17 responses to
purified protein derivative (PPD) of M. bovis [49]. The calf immune
system has been found to serve as a good model of the human
immune system for the study of tuberculosis and M. bovis BCG
vaccination [50,51]. In addition, the concentration of 25(OH)D3
circulating in blood is similar between cattle and humans with
typical concentrations ranging from 20 to 100 ng/mL in both
species [52,53,54]. In cattle and humans symptoms of vitamin D
toxicity is rarely observed with circulating 25(OH)D3 concentra-
tions below 200 ng/mL [8,55,56]. Finally, as mentioned already,
local control of 1,25(OH)2D3 synthesis by the immune system and
1,25(OH)2D3 –regulation of T cell responses is similar between
cattle and humans. Therefore, the outcome of this study will
provide insight on the mechanisms of vitamin D signaling in the
human and bovine immune systems.
Materials and Methods
Animals
Twelve male Holstein calves that were approximately 5 months
to 12 months of age were used for this study. At 14 d of age, 8
calves were vaccinated subcutaneously in the midcervical region
with 10
7 cfu of M. bovis BCG (Pasteur strain). M. bovis BCG was
prepared for vaccination as previously described [57]. The
remaining 4 calves were not vaccinated. The NADC animal care
and use committee approved the care and treatment of animals
used in this study (Animal Protocol #ARS-3982).
Peripheral blood mononuclear cell cultures
Blood from the jugular vein was collected in 26 acid citrate
dextrose. Blood was centrifuged and buffy coats were collected.
Contaminating RBCs were removed by hypotonic lysis. PBMCs
were isolated by density gradient centrifugation. PBMC were
resuspended in RPMI 1640 (Sigma-Aldrich, St. Louis, MO)
supplemented with 50 mg/ml gentamicin (Invitrogen, Carlsbad,
CA). For gene expression assays, PBMCs were cultured at a
concentration of 1.5610
7 cells/ml in 96-well (200 ml/well) or 6-
well (2 ml/well) tissue culture plates for 24 h at 37uCi n5 %C O 2.
For determination of nitric oxide and IFN-c production, PBMCs
were cultured at 1610
6 cells/mL in a 96-well plate (200 ml/well)
for 24, 48, and 72 h.
LPS from Serratia marcescens (Sigma-Aldrich), pokeweed mitogen
(PWM; Sigma-Aldrich) and purified protein derivative from M. bovis
(M. bovis PPD) (Prionics, Zurich, Switzerland) were added at 100 ng/
ml, 5 mg/ml, and 10 mg/ml, respectively, to PBMC cultures. The
vitamin D metabolites, 25(OH)D3 and 1,25(OH)2D3,( S i g m a -
Aldrich) were diluted in 100% ethanol and added to fetal bovine
serum (FBS; Hyclone, Waltham, MA) at 106 the final desired
concentration. The concentrations of 25(OH)D3and 1,25(OH)2D3 in
ethanol were confirmed by UV spectroscopy. FBS with ethanol
(vehicle)orthevitaminDmetaboliteswasaddedtoPBMCculturesto
a final concentration of 10% FBS. The final concentration of ethanol
did not exceed 0.04%.
Cell sorting
PBMCs from 7 BCG-vaccinated and 4 non-vaccinated calves
were cultured with 10 mg/ml M. bovis PPD and 0 or 100 ng/ml
25(OH)D3 for 24 h in 6 well plates. Cells were removed from the
wells with cold PBS and scraping. Cells were labeled with anti-
CD14 (CAM36A; mouse IgG1), anti-IgM (PIG45A; mouse
IgG2b), or a cocktail of anti-CD3 (MM1A; mouse IgG1), anti-
CD4 (CACT83B; mouse IgM), anti-CD8 (MAQ111A; mouse
IgM) and anti-cdTCR (CACT61A; mouse IgM). Cells labeled
with the cocktail of CD3, CD4,CD8, and cdTCR antibodies are
simply referred to as CD3
+ cells. All primary antibodies were
purchased from VMRD, Pullman, WA. Cells were then labeled
with anti-mouse IgG1-PE (Becton Dickinson, San Jose, CA), anti-
mouse IgG2b-Cy5 (Southern Biotech, Birmingham, AL), or a
combination of anti-mouse IgG1-PE and anti-mouse IgM-PE
(Becton Dickinson) secondary antibodies. Labeled cells were
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Cell Sorting System (BD Biosciences, San Jose, CA). Approxi-
mately 10
6 cells of each sub-population with .95% purity were
collected from each PBMC culture.
Relative gene expression
RNA was isolated from PBMC using the RNeasy Mini Kit
(Qiagen, Valencia, CA). RNA samples were reverse transcribed to
cDNA in 20 ml reactions using the High Capacity Reverse
Transcription Kit with RNase inhibitor and random primers
(Applied Biosystems, Foster City, CA). The reverse transcription
reactions were incubated for 2 h at 37uC followed by 5 s at 85uC
and finally cooled to 4uC. The cDNA samples were diluted 1:10 in
water and stored at 220uC.
The amount of specific cDNA transcripts in each sample was
determined using the 7300 Real-Time PCR System (Applied
Biosystems). Each reaction contained 12.5 ml SYBR Green Master
Mix (Applied Biosystems), 7.5 ml of cDNA sample, and 5 mlo f
10 mM forward and 10 mM reverse primers. Reactions were
incubated as follows: 95uC for 10 min followed by 40 cycles of
95uC for 15 s and 60uC for 60 s. Primer sets were designed with
Primer3 (http://frodo.wi.mit.edu/primer3) [58] to span intron-
exon boundaries and are listed in Table 1. Primers were purchased
from Integrated DNA Technologies (Coralville, IA). The efficiency
of each primer set was determined as previously described [20]
and fit the criteria required for quantification by real-time PCR
[59]. The specificity of each primer set was verified by melting
curve analysis and gel electrophoresis. The amounts of cDNA
transcripts were normalized to ribosomal protein S9 (RPS9)
cDNA. Expression of RPS9 also was compared to b-actin and
GAPDH expression to verify its stability over treatment condi-
tions. The relative expression of each gene was determined using
the 2
2DDCt method [59]. The expression of each gene is relative to
the normalized amount of each cDNA transcript in the non-
stimulated controls for each experiment.
Measurement of nitric oxide production
Production of nitric oxide by PBMCs was determined by
measurement of nitrite in the culture supernatant by using the
Griess assay as previously described [20]. Supernatants (100 mL)
from PBMC cultures were added to an equal volume of Griess
reagent [0.5% sulfanilamide, 2.5% phosphoric acid, and 0.05% N-
(1-naphthyl) ethylenediamine dihydrochloride; Sigma-Aldrich] in
a 96-well clear bottom plate. Absorbance at 550 nm in each well
was measured using a FlexStation 3 plate reader (Molecular
Devices, Sunnyvale, CA). Absorbance values were converted to
micromoles per liter using a standard curve that was generated by
addition of 0 to 100 mM sodium nitrite to fresh culture media.
Measurement of IFN-c production
The concentration of IFN-c in PBMC culture supernatants was
determined by an ELISA using the Endogen Bovine IFNc
Screening Set (Pierce Biotechnology, Rockford IL) according to
the manufacturers instructions. The absorbance at 450 nm minus
the absorbance at 550 nm was measured with the FlexStation 3
plate reader and the values were converted to picograms per
milliliter by using a standard curve.
Statistical Analysis
Analysis of variance was performed using PROC GLM of SAS
(SAS Institute INC., Cary, NC). The model accounted for effects
of treatment, cell type, and calf or vaccination status. DDCt values
were used in the analyses of gene expression. The average DDCt
values 6 SE were transformed using the equation 2
2DDCt. The
expression of each gene is presented as the mean fold increase 6
SE relative to non-stimulated controls. Multiple comparison tests
of the means were made using the Tukey adjustment.
Results
M. bovis PPD-activation of vitamin D signaling in PBMCs
By stimulating PBMCs from M. bovis-BCG-vaccinated calves
with LPS, PWM, or M. bovis PPD, we found that 1a-OHase gene
expression in the PBMCs was upregulated by LPS, PWM, and M.
bovis PPD stimulation relative to non-stimulated PBMCs
(P,0.001; Fig. 1A). In contrast, VDR gene expression in the
PBMC cultures was not upregulated by any of the stimulants
(Fig. 1B). We also measured iNOS, RANTES, IFN-c, IL-17A, and
IL-17F gene expression. Neither iNOS nor RANTES was affected
by M. bovis PPD or LPS stimulation, but RANTES was
upregulated by PWM stimulation (Fig. 1C and D). IFN-c, IL-
17A, and IL-17F were upregulated in PBMCs stimulated with
PWM or M. bovis PPD, however, they were not affected by LPS
stimulation (Fig. 1E–G).
Previously, treatment of M. bovis PPD-stimulated PBMCs with
exogenous 1,25(OH)2D3 was found to suppress IFN-c production
[29]. And recently, we showed that conversion of 25(OH)D3 to
1,25(OH)2D3 by 1a-OHase in activated bovine monocytes up-
Table 1. Primer sequences for real-time PCR.
Gene (alternate name) Accesion no.
1 Strand Sequence (59 -3 9)
1a-OHase (CYP27B1)
2 NM_001192284 Forward Reverse TGGGACCAGATGTTTGCATTCGC TTCTCAGACTGGTTCCTCATGGCT
24-OHase (CYP24A1)
2 NM_001191417 Forward Reverse GAAGACTGGCAGAGGGTCAG CAGCCAAGACCTCGTTGATT
IFN-c NM_174086 Forward Reverse GATTCAAATTCCGGTGGATG GCAGGAGGACCATTACGTTG
IL-17A NM_001008412 Forward Reverse TCCATCTCACAGCGAGCACAAG AGCCACCAGACTCAGAAGCAGTA
IL-17F NM_001192082 Forward Reverse CTCCCCTTGGGATTACAACA TTCAGGGTCCTGTCTTCCTG
iNOS
2 NM_001076799 Forward Reverse GATCCAGTGGTCGAACCTGC CAGTGATGGCCGACCTGATG
RANTES (CCL5)
2 NM_175827 Forward Reverse CACCCACGTCCAGGAGTATT CTCGCACCCACTTCTTCTCT
RPS9
2 NM_001101152 Forward Reverse GTGAGGTCTGGAGGGTCAAA GGGCATTACCTTCGAACAGA
VDR NM_001167932 Forward Reverse AGCCACCGGCTTCCATTTCA AACAGCGCCTTCCGCTTCAT
1Accesion numbers for mRNA sequences from NCBI database.
2Primer sequences have been published previously [20].
doi:10.1371/journal.pone.0021674.t001
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OHase gene expression was upregulated in M. bovis PPD-
stimulated PBMC, we wanted to determine the effect of
25(OH)D3 on gene expression in M. bovis PPD-stimulated PBMCs.
Addition of 100 ng/mL 25(OH)D3, a physiological concentra-
tion [54], to resting PBMCs did not affect expression of any of the
genes tested (Fig. 2). Addition of 4 ng/mL 1,25(OH)2D3,a
concentration 2 to 3 orders of magnitude greater than normal
serum 1,25(OH)2D3, did upregulate 24-OHase and RANTES
gene expression in resting PBMCs (P,0.05; Fig. 2A and C).
Stimulation of PBMCs with M. bovis PPD suppressed 24-OHase
gene expression (P,0.05; Fig. 2A), which is consistent with LPS
stimulation of bovine monocytes [20]. However, addition of either
25(OH)D3 or 1,25(OH)2D3 to stimulated PBMCs increased 24-
OHase gene expression relative to PBMCs that were stimulated
with M. bovis PPD alone. Similarly, iNOS and RANTES were
upregulated in M. bovis PPD-stimulated PBMCs treated with
25(OH)D3 or 1,25(OH)2D3 compared to PBMCs that were
stimulated with M. bovis PPD alone (P,0.05; Fig. 2B and C).
IL-17F gene expression was decreased in stimulated PBMCs that
were treated with 1,25(OH)2D3 (P,0.05; Fig. 2F). IFN-c, IL-17A,
and IL-17F gene expression was decreased by 25(OH)D3
treatment, but the decrease was not statistically significant
(P.0.05; Fig. 2D–F).
Figure 1. 1a-hydroxylase (1a-OHase) gene expression in PBMC cultures. PBMC cultures from eight M. bovis-BCG-vaccinated calves were
treated with 100 ng/ml LPS, 5 mg/ml PWM, or 10 mg/ml of M. bovis PPD or received no treatment (CTRL) as indicated for 24 h. The amount of 1a-
OHase (A), VDR (B), iNOS (C), RANTES (D), IFN-c (E), IL-17A (F), and IL-17F (G) mRNA was determined by quantitative real-time RT-PCR and was
normalized to the amount of RPS9 mRNA in each sample. Expression of each gene is relative to non-stimulated cultures. Error bars represent SE.
*** Mean is different from non-stimulated PBMC; P,0.001.
doi:10.1371/journal.pone.0021674.g001
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IFN-c production by M. bovis PPD-stimulated PBMCs treated with
graded doses of 25(OH)D3 form 0 to 125 ng/mL (Fig. 3). Like
iNOS gene expression, 100 ng/mL 25(OH)D3 increased nitric
oxide production, as measured by nitrite in the culture
supernatant, after 48 and 72 h in culture (Fig. 3A). Furthermore,
treatment with 25 to 125 ng/mL 25(OH)D3 increased nitric oxide
production by the stimulated PBMCs in a dose dependent
manner. Addition of 25(OH)D3 suppressed IFN-c production in
M. bovis PPD-stimulated cultures after 24, 48, and 72 h in culture
(P,0.05; Fig. 3B), but the effect of 25(OH)D3 did not occur in
linear fashion.
Cell type-specific expression of 1a-OHase and VDR
Several cell types have been reported to express 1a-OHase,
including activated monocytes, T cells, and B cells [41,43,44]. We
sorted PBMCs that had been stimulated with M. bovis PPD from
BCG-vaccinated animals according to surface expression of CD3,
IgM, and CD14 by using FACS (Fig. 4) to determine what
populations of cells in PBMCs were expressing 1a-OHase upon
activation. By sorting the stimulated PBMCs, we found that 1a-
OHase was predominantly expressed in the CD14
+ population of
cells (P,0.001; Fig. 4A). 1a-OHase expression was also induced in
IgM
+ cells from vaccinated calves (P,0.001). Relative to 1a-
OHase expression in non-stimulated, non-sorted PBMCs, the
expression of 1a-OHase did not increase in the CD3
+ cells isolated
from the stimulated PBMC cultures (Fig. 4A). Unlike 1a-OHase,
VDR gene expression did not differ significantly between cell types
in PBMC cultures from vaccinated calves, but IgM
+ cells from
25(OH)D3 treated cultures did have somewhat lower VDR
expression (Fig. 4B).
Cell type-specific effects of 25(OH)D3 on gene expression
We also compared gene expression in cells from M. bovis PPD-
stimulated PBMCs that were treated with 100 ng/ml 25(OH)D3
with cells from M. bovis PPD-stimulated PBMCs that were not
treated with 25(OH)D3. Treatment with 25(OH)D3 increased 24-
OHase, iNOS, and RANTES gene expression in both CD14
+ cells
and IgM
+ cells from the BCG-vaccinated calves (P,0.05; Fig. 4C–
E). In contrast, 25(OH)D3 treatment decreased expression of IFN-
c by over 60% and IL-17F by nearly 50% in the CD3
+ cells from
the BCG-vaccinated calves (P,0.05; Fig. 4F and H). IL-17A
expression in the CD3
+ cells was also down-regulated by
25(OH)D3 treatment, but to a lesser extent (P.0.05; Fig. 4G).
Comparison of responses between BCG-vaccinated and
non-vaccinated animals
Finally, we compared changes in gene expression caused by M.
bovis PPD stimulation and 25(OH)D3 in cells from non-vaccinated
animals to the changes observed in cells from BCG-vaccinated
animals. In PBMCs from non-vaccinated animals, 1a-OHase was
induced in CD14
+ cells by M. bovis PPD stimulation like in CD14
+
cells from BCG-vaccinated animals (Fig. 4A). Unlike the PBMCs
from BCG-vaccinated calves, VDR was not detected in IgM
+ cells
Figure 2. Effects of 1,25(OH)2D3 and 25(OH)D3 on gene expression in PBMC cultures. PBMC cultures from eight M. bovis-BCG-vaccinated
calves were treated with 0 or 10 mg/ml of M. bovis purified protein derivative (PPD), 100 ng/ml of 25(OH)D3, and 4 ng/ml 1,25(OH)2D3 as indicated for
24 h. The amount 24-OHase (A), iNOS (B), RANTES (C), IFN-c (D), IL17A (E), and IL-17F (F) mRNA was determined by quantitative real-time RT-PCR. Each
gene was normalized to the amount of RPS9 mRNA in each sample. Expression of each gene is relative the expression of that gene in non-stimulated
cultures. Error bars represent SE. * Means are different; P,0.05.
doi:10.1371/journal.pone.0021674.g002
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CD3
+ and CD14
+ cells was similar between vaccinated and non-
vaccinated calves. Neither 24-OHase, iNOS, or RANTES
expression was affected by 25(OH)D3 in CD14
+ cells and IgM
+
cells from the non-vaccinated animals like it was in the BCG-
vaccinated animals (Fig. 4C–E). Finally, IFN-c, IL-17A, and IL-
17F were not induced by M. bovis PPD stimulation in the CD3
+
cells from non-vaccinated animals as they were in CD3
+ cells from
BCG-vaccinated animals (Fig. 4F–H).
Discussion
For over two decades now, 1,25(OH)2D3 has been known as an
important regulator of adaptive immunity, suppressing lympho-
cyte proliferation and IFN-c production [28,60]. The implications
of 1,25(OH)2D3 on adaptive immunity are further realized in
animal models of T cell-mediated autoimmunity as 1,25(OH)2D3
inhibits disease progression [32,34,61,62]. Recently, 1,25(OH)2D3
also was found to be an important regulator of innate immunity by
enhancing antimicrobial properties of macrophages [16,18].
Vitamin D-mediated immune responses, however, do not
correlate with the circulating concentration of 1,25(OH)2D3
[38,39]. Therefore, local synthesis of 1,25(OH)2D3 is a critical
factor in regulating both innate and adaptive immunity.
Previously, induction of 1a-OHase expression in macrophages
was shown to occur upon activation by TLR 2/1 or TLR 4
signaling and enable them to convert 25(OH)D3 to 1,25(OH)2D3
[20,41,63]. Synthesis of 1,25(OH)2D3 in macrophages, in turn,
enhanced their innate antimicrobial properties in an intracrine
fashion [48]. In this study, we give evidence that endogenous
synthesis of 1,25(OH)2D3 also occurs in antigen-stimulated PBMC
cultures and regulates key aspects of adaptive immunity.
In this study we found that 1a-OHase gene expression was
induced in CD14
+ cells (monocytes/macrophages) and IgM
+ (B
cells), but not in CD3
+ (T cells) cells in M. bovis PPD-stimulated
PBMC cultures. Furthermore, treatment of M. bovis PPD-
stimulated PBMC cultures with 25(OH)D3 enhanced iNOS and
RANTES expression in monocytes and B cells and suppressed
antigen-specific IFN-c and IL-17F responses in T cells. Based on
this evidence, we hypothesize that 1,25(OH)2D3 was produced in
monocytes and B cells acted on monocytes and B cells in an
intracrine fashion to upregulate iNOS and RANTES expression
and on T cells in a paracrine fashion to suppress M. bovis PPD-
specific IFN-c and IL-17F responses (Fig. 5).
M. bovis PPD is a crude extract and as such likely contains
antigens that activate both the innate and adaptive immune
systems. Therefore, in PBMC cultures innate antigen presenting
cells (e.g., monocytes) recognize TLR ligands, such as lipoproteins,
become activated and then express 1a-OHase. The APCs also
internalize protein from the M. bovis PPD, process it and then
present it on their surface as peptide associated with MHC.
Activation of T cells specific for M. bovis PPD is then caused by the
Figure 3. Effects of 1,25(OH)2D3 and 25(OH)D3 on nitrite oxide and IFN-c production. PBMCs from seven M. bovis-BCG-vaccinated calves
were cultured at a concentration of 1610
6 cells/mL with 0 or 10 mg/ml of M. bovis purified protein derivative (PPD), 25 to 125 ng/ml of 25(OH)D3,o r
4 ng/ml 1,25(OH)2D3 as indicated for 24, 48, and 72 h. A) The nitrite concentration in the culture supernatants was measured by using the Griess
assay and used as an indicator of nitric oxide production by the PBMCs. B) The concentration of IFN-c in the culture supernatants was measured by an
ELISA specific for bovine IFN-c. Data represents the average concentration of nitrite or IFN-c in culture supernatants harvested at 24, 48, and 72 h.
Error bars represent SE. * Mean is different (P,0.05) from PBMC cultures treated with M. bovis PPD alone for the corresponding time point.
doi:10.1371/journal.pone.0021674.g003
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MHC/antigen. Likewise, B cells recognize antigen through IgM
on their surfaces, and along with co-stimulation from T cells,
become activated and express 1a-OHase. We suggest that
production of 1,25(OH)2D3 by 1a-OHase in activated monocytes
and B cells can alter the IFN-c and IL-17F responses that are the
result of the TCR/MHC/antigen interaction between T cells and
APCs.
There are multiple possibilities as to how 1,25(OH)2D3
suppressed IFN-c and IL-17F gene expression in T cells. VDR
expression in the T cells was similar to that in monocytes in this
study and purified T cells do respond to 1,25(OH)2D3 [25,64].
Also, T cell VDR expression is required for 1,25(OH)2D3-
mediated inhibition of experimental autoimmune encephalomy-
elitis in mice [35]. Therefore, the T cells in the PBMC cultures
likely had the ability to respond to 1,25(OH)2D3 secreted from the
monocytes and B cells. Consequently, activation of the VDR in T
cells could have directly suppressed IFN-c and IL-17F expression.
However, 1,25(OH)2D3 failed to suppress IFN-c production in
fully differentiated Th1 cells [61]; so, 1,25(OH)2D3 may have
regulated genes in T cells that influenced T cell differentiation or
sensitized them to apoptosis. Alternatively, up-regulation of nitric
oxide production by 1,25(OH)2D3 in monocytes and B cells could
have induced apoptosis in the surrounding T cells and resulted in
suppressed IFN-c and IL-17F expression. A combination of
several mechanisms also is possible and we have not ruled out the
Figure 4. Cell-type specific regulation of vitamin D signaling. PBMCs from seven M. bovis-BCG-vaccinated calves (black bars) and four non-
vaccinated calves (grey bars) were treated with 10 mg/ml of M. bovis PPD and 0 or 100 ng/ml 25(OH)D3 as indicated for 24 h. After treatment, PBMCs
were sorted by FACS according to CD3/4/8/cdTCR (CD3; T cell), IgM (B cell), and CD14 (monocyte) expression on the cell surface. The amount of 1a-
OHase (A), VDR (B), 24-OHase (C), iNOS (D), RANTES (E), IFN-c (F), IL-17A (G), and IL-17F (H) mRNA in the sorted cells was determined by quantitative
real-time RT-PCR. The amount of mRNA for each gene was normalized to the amount of RPS9 mRNA in each sample. Expression of each gene in each
cell type is relative to non-stimulated, non-sorted PBMCs. Error bars represent SE. * P,0.05, *** P,0.001, Means are different.
doi:10.1371/journal.pone.0021674.g004
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1,25(OH)2D3. Therefore, further experiments are needed to
determine if regulation of T cell responses by 1,25(OH)2D3 strictly
depends on synthesis of 1,25(OH)2D3 in monocytes or B cells and
how 1,25(OH)2D3 is regulating T cell responses.
In any case, treatment of antigen-stimulated PBMCs with
25(OH)D3 suppressed antigen-specific IFN-c and IL-17F expres-
sion in T cells, which indicates that synthesis of 1,25(OH)2D3 by
immune cells has significant implications in regulating adaptive
immunity. IFN-c is a potent activator of macrophages and is
mainly produced by Th1 cells [65]. Th1-mediated responses are
critical in the defense against intracellular infections, such as
tuberculosis [66,67]. IL-17A and IL-17F are produced by Th17
cells and play major roles in neutrophil recruitment and protection
against intracellular and extracellular bacterial infections
[68,69,70]. Self reactive Th1 and Th17 cells, however, are
involved in the development of autoimmune disorders [71] and
inhibition of animal models of autoimmunity by 1,25(OH)2D3 is
thought to occur, in part, by suppression of self-reactive Th1 and
Th17 cells [72]. Although suppression of Th1 and Th17 responses
to bacterial antigens by 1,25(OH)2D3 would seem to attenuate the
immune response against bacterial infections, keep in mind that
1,25(OH)2D3 also enhances the antimicrobial activity of macro-
phages [41]. So overall, production of 1,25(OH)2D3 by immune
cells serves to limit inflammation caused by Th1 and Th17 effector
cells, but ultimately improves defense against bacterial infections
by boosting the innate antimicrobial response.
In addition to suppression of T cell responses by 1,25(OH)2D3
synthesis in PBMC cultures, treatment of PBMCs with 25(OH)D3
upregulated antigen-specific B cell iNOS and RANTES expres-
sion. We had previously shown that monocyte iNOS and
RANTES expression depends on availability of 25(OH)D3 [20],
but not B cell iNOS and RANTES. Nitric oxide produced by
iNOS in macrophages is considered to be an antimicrobial
molecule. However, nitric oxide produced by the monocytes and B
cells may suppress proliferation of T cells [73]. So, as mentioned
above, 1,25(OH)2D3 may suppress T cell responses in part by
enhancing B cell and monocyte iNOS expression. RANTES is a
Figure 5. Regulation of T cells through a paracrine mechanism of vitamin D signaling. 1) 1a-hydroxylase (1a-OHase) gene expression is
induced in monocytes by recognition of pathogen associated molecular patterns (PAMP) by toll-like receptors (TLR) and interferon-c (IFN-c) from Th1
cells, and in B cells by antigen recognition by the B cell receptor (IgM) along with co-stimulation by antigen-specific T cells. 2) 25-hydroxyvitamin D3
(25D3) is converted to 1,25-dihydroxyvitamin D3 (1,25D3)b y1 a-OHase. 3) 1,25(OH)2D3 produced in monocytes and B cells activates the vitamin D
receptor (VDR) and enhances iNOS and RANTES expression in monocytes and B cells. 4) 1,25(OH)2D3 secreted from monocytes and B cells suppresses
IFN-c and interleukin-17F (IL-17F) expression in T cells. Direct suppression of IFN-c and IL-17F expression by the 1,25(OH)2D3, however, is not certain.
Instead, 1,25(OH)2D3 may influence T cell development, suppress proliferation, or sensitize them to apoptosis.
doi:10.1371/journal.pone.0021674.g005
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also has been found to be expressed by alveolar macrophages in
cattle [75]. We speculate that upregulation of RANTES in
monocytes and B cells by 1,25(OH)2D3 would enhance recruit-
ment of immune cells to the site of inflammation, but the
implications of 1,25(OH)2D3-upregulation of RANTES in mono-
cytes and B cells will need to be investigated.
Finally, the ability of 1a-OHase in monocytes and B cells to
synthesize 1,25(OH)2D3, and subsequently regulate 1,25(OH)2D3-
mediated immune responses, depends on the availability of
25(OH)D3. The circulating concentration of 25(OH)D is primarily
regulated by dietary intake of vitamin D3 and sun exposure [76].
Current recommendations for vitamin D in humans and cattle
target a circulating concentration of 25(OH)D of 20 to 50 ng/ml
[55,77]. However, 25(OH)D concentrations above 30 ng/ml may
be necessary for optimal immune function [1]. In addition,
vitamin D insufficiency (serum 25(OH)D below 30 ng/ml) and
even deficiency (serum 25(OH)D below 20 ng/ml) is widespread,
indicating that current recommendations for vitamin D3 intake
may be inadequate [78,79]. Previously, and here, we have shown
that 1,25(OH)2D3-regulated innate immune responses increase
linearly from 0 to 125 ng/ml of 25(OH)D3 [20]. This observation
leads to the question of what concentration is necessary for optimal
immune functionality if below 30 ng/ml is insufficient? Based on
the requirement of 25(OH)D3 by the immune system for signaling
mechanisms and evidence from epidemiological studies, vitamin D
requirements need to be re-evaluated to ensure proper immune
function.
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